An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80mg+ Amlodipine 5 mg Fixed-dose Combination vs. Telmisartan 80 mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80mg Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2012
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Telmisartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 21 Dec 2012 Results have been reported in an Astellas Pharma media release.
- 27 Jul 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 27 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.